Biotech

All Articles

Pfizer, Valneva show lyme disease go successful for second booster

.Pfizer and also Valneva might have about two additional years to wait before they produce the very ...

Fierce Biotech Managing Editor Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Let's study a discussion along with Ayla Ellison, Brutal Biotech Managing Editor and also Michelle ...

New data show how Bayer's asundexian fell short to stop movements

.Bayer put on hold the phase 3 test for its own aspect XIa inhibitor asundexian late last year after...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials

.Sanofi is actually still set on taking its various sclerosis (MS) med tolebrutinib to the FDA, exec...

Galapagos' stock up as fund shows intent to shape its own development

.Galapagos is actually coming under added stress coming from entrepreneurs. Having constructed a 9.9...

Cell- focused Sana gathers very first CSO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant management hirings, shootings...

Allist pays Jacobio $21M, landing role in Mandarin KRAS ethnicity

.Shanghai Allist Pharmaceuticals has actually bought on its own a starring role in China's KRAS mark...

ReNeuron leaving behind intention swap after overlooking fundraising objective

.ReNeuron has actually joined the lengthy checklist of biotechs to leave behind Greater london's goa...

MBX apply for IPO to take challenger to Ascendis into stage 3

.MBX Biosciences has actually added to the recent flurry of IPO filings. The biotech, which submitte...

FDA broadens probing in to Lykos' MDMA trials: WSJ

.For Lykos Therapies and the provider's would-be MDMA-assisted therapy for post-traumatic stress dis...